Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access

Editor-in-Chief:

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France

Back

Become EABM
Become Reviewer

The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy

Volume:12   Issue: 9
Pp: 1001-1014
Alexander J. A. Deutsch, Hannes Angerer, Tamara E. Fuchs and Peter Neumeister
DOI: 10.2174/187152012803529619

Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling

Volume:12   Issue: 9
Pp: 1015-1024
Mariana Reis, Ricardo J. Ferreira, Julianna Serly, Noelia Duarte, Ana M. Madureira, Daniel J. V. A. Santos, Joseph Molnar and Maria-Jose U. Ferreira
DOI: 10.2174/187152012803529655

The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer

Volume:12   Issue: 9
Pp: 1025-1044
Ioly Kotta-Loizou, Constantinos Giaginis and Stamatios Theocharis
DOI: 10.2174/187152012803529664

CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?

Volume:12   Issue: 9
Pp: 1045-1057
Alicia Gonzalez-Martin, Emilia Mira and Santos Manes
DOI: 10.2174/187152012803529637

Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy

Volume:12   Issue: 9
Pp: 1058-1070
Jose Prados, Consolacion Melguizo, Raul Ortiz, Celia Velez, Pablo J. Alvarez, Jose L. Arias, Maria A. Ruiz, Visitacion Gallardo and Antonia Aranega
DOI: 10.2174/187152012803529646

Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones

Volume:12   Issue: 9
Pp: 1071-1080
Manja Zec, Tatjana Srdic-Rajic, Aleksandra Konic-Ristic, Tamara Todorovic, Katarina Andjelkovic, Ivana Filipovic-Ljeskovic and Sinisa Radulovic
DOI: 10.2174/187152012803529682

Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?

Volume:12   Issue: 9
Pp: 1081-1087
Zhaowei Zhu, Zhoujun Shen and Chen Xu
DOI: 10.2174/187152012803529673

Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma

Volume:12   Issue: 9
Pp: 1088-1097
Ahmed Temirak, Mona Abdulla and Mahmoud Elhefnawi
DOI: 10.2174/187152012803529718

Anti-cancer Effects of Curcumin on Head and Neck Cancers

Volume:12   Issue: 9
Pp: 1110-1116
Wei Gao, Jimmy Yu-Wai Chan, William Ignance Wei and Thian-Sze Wong
DOI: 10.2174/187152012803529736

Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents

Volume:12   Issue: 9
Pp: 1117-1131
David E. Zembower, Yongping Xie, Ali Koohang, Mary J. Kuffel, Matthew M. Ames, Yasheen Zhou, Rama Mishra, Aye Aye Mar, Michael T. Flavin and Ze-Qi Xu
DOI: 10.2174/187152012803529628

Dual Roles of Sulforaphane in Cancer Treatment

Volume:12   Issue: 9
Pp: 1132-1142
Tongzhen Xu, Dongmei Ren, Xuefei Sun and Guotao Yang
DOI: 10.2174/187152012803529691

Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules

Volume:12   Issue: 9
Pp: 1143-1155
Michael Hedvat, Luni Emdad, Swadesh K. Das, Keetae Kim, Santanu Dasgupta, Shibu Thomas, Bin Hu, Shan Zhu, Rupesh Dash, Bridget A. Quinn, Regina A. Oyesanya, Timothy P. Kegelman, Upneet K. Sokhi, Siddik Sarkar, Eda Erdogan, Mitchell E. Menezes, Praveen Bhoopathi, Xiang-Yang Wang, Martin G. Pomper, Jun Wei, Bainan Wu, John L. Stebbins, Paul W. Diaz, John C. Reed, Maurizio Pellecchia, Devanand Sarkar and Paul B. Fisher
DOI: 10.2174/187152012803529709